Search PubMed⌕ Search

Biomedical subjects

Michael May

Publications and source records attributed to Michael May.

7 recordsLinked to original sources

Vacuum electrolysis reactor technique for quantitation of 13-carbon isotope enrichment at the C1-position of formic acid and acetic acid.

A specialized vacuum electrolysis reactor was designed, constructed, and utilized for 13-carbon isotope analysis of formic acid-13C and acetic acid-13C, each highly enriched at the C1-position. This reusable reactor was equipped with two platinum wire electrodes, miniature stir bar, and sidearm reaction chamber. The associated technique developed for 13-carbon isotope analysis is based upon electrolytic generation of carbon dioxide into the preevacuated reactor followed by gas inlet mass spectrometry. It proved practical to degas and electrolyze 95% formic acid (without added electrolyte) due to adequate ionic conductivity. Formic acid-13C (nominally 99 at. % 13C) was measured by electrolytic CO2 generation to be 98.9 at. % 13C. To analyze various 13C-isotopic permutations of acetic acid, lithium and acid were separately added to reactor compartments, vacuum degassed, and stirred to produce an acidic solution. Thus, acetic acid-1-13C that was nominally 99 at. % 13C1 was determined by vacuum electrolysis to be 98.9 at. % 13C1. Further, acetic acid-2-13C that was isotope depleted at the C1-position (and known to be 99 at. % 13C at C2) gave 0.8 at. % 13C by mass spectrometry.

Journal Article↗

ARB: a software environment for sequence data.

The ARB (from Latin arbor, tree) project was initiated almost 10 years ago. The ARB program package comprises a variety of directly interacting software tools for sequence database maintenance and analysis which are controlled by a common graphical user interface. Although it was initially designed for ribosomal RNA data, it can be used for any nucleic and amino acid sequence data as well. A central database contains processed (aligned) primary structure data. Any additional descriptive data can be stored in database fields assigned to the individual sequences or linked via local or worldwide networks. A phylogenetic tree visualized in the main window can be used for data access and visualization. The package comprises additional tools for data import and export, sequence alignment, primary and secondary structure editing, profile and filter calculation, phylogenetic analyses, specific hybridization probe design and evaluation and other components for data analysis. Currently, the package is used by numerous working groups worldwide.

Data Display↗

Electrochemistry of niobium(V) in sulfuric and methanesulfonic acids: formation of the Nb3O2(SO4)6(H2O)(3)(5-) cluster and designed electrochemical generation of "Nb3O2" core clusters by double potential pulse electrolysis.

The electrochemical and spectroelectrochemical properties of niobium(V) and the Nb(3)O(2)(SO(4))(6)(H(2)O)(3)(5-) cluster in sulfuric acid and methanesulfonic acid were investigated using cyclic voltammetry, constant potential electrolysis, and spectroelectrochemistry. These chemical systems were suitable to probe the formation of "Nb(3)O(2)" core trinuclear clusters. In 9 M H(2)SO(4) the cluster Nb(3)O(2)(SO(4))(6)(H(2)O)(3)(5-) exhibited a reversible 1-electron reduction peak at E(pc) = -1.30 V vs Hg/Hg(2)SO(4) electrode, as well as a 4-electron irreversible oxidation peak at E(pa) = -0.45 V. Controlled potential reduction at E = -1.40 V produced the green Nb(3.33+) cluster anion Nb(3)O(2)(SO(4))(6)(H(2)O)(3)(6-). In 12 M H(2)SO(4) Nb(V) displayed two reduction peaks at E(pc) = -1.15 V and E(pc) = -1.30 V. It was determined that the first process involves a quasi-reversible 2-electron reduction. After reduction of Nb(V) to Nb(III) the following chemical step involves formation of [Nb(III)](2) dimer, which further reacts with Nb(V) to produce the Nb(3)O(2)(SO(4))(6(H(2)O)(3)(5-) cluster (ECC process). The second reduction peak at E(pc) = -1.30 V corresponds to further 2-electron reduction of Nb(III) to Nb(I). The electrogenerated Nb(I) species also chemically reacts with starting material Nb(V) to produce additional [Nb(III)](2). In 5 M H(2)SO(4), the rate of the second chemical step in the ECC process is relatively slower and reduction of Nb(V) at E = -1.45 V/-1.2 V produces a mixture of Nb(3)O(2)(SO(4))(6)(H(2)O)(3)(5-) and [Nb(III)](2) dimer. [Nb(III)](2) can be selectively oxidized by two 2-electron steps at E = -0.65 V to Nb(V). However, if the oxidation is performed at E = -0.86 V, the product is Nb(3)O(2)(SO(4))(6)(H(2)O)(3)(5-). A double potential pulse electrolysis waveform was developed to direct the reduction of Nb(V) toward selective formation of the Nb(3)O(2)(SO(4))(6)(H(2)O)(3)(5-) cluster. Proper application of dc-voltage pulses alternating between E(1) = -1.45 V and E(2) = -0.86 V yields only the target trinuclear cluster. Analogous double potential pulse electrolysis of Nb(V) in methanesulfonic acid generates the "Nb(3)O(2)" core cluster Nb(3)O(2)(CH(3)SO(3))(6)(H(2)O)(3)(+).

Journal Article↗

Secondary myeloid leukemia and myelodysplastic syndromes in patients treated for Hodgkin's disease: a report from the German Hodgkin's Lymphoma Study Group.

PURPOSE: To assess the incidence and outcome of secondary acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) in patients with Hodgkin's disease (HD). PATIENTS AND METHODS: Between 1981 and 1998, the GHSG conducted three trial generations for early, intermediate, and advanced HD involving a total of 5,411 patients (called HD1 through HD9). RESULTS: A total of 46 patients with secondary AML/MDS were identified. The median age at diagnosis of leukemia was 47 years (range, 22 to 79 years). Primary therapy was as follows: radiotherapy alone (n = 4); doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD; n = 1); cyclophosphamide, vincristine, procarbazine, and prednisone (COPP)/ABVD or similar (n = 30); bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone (BEACOPP) baseline (n = 2); and BEACOPP escalated (n = 9). Twelve patients developed AML/MDS after salvage therapy, including four patients who developed AML/MDS after high-dose chemotherapy with autologous stem-cell transplantation. Thirty-six of the secondary malignancies were AML, and 10 malignancies were MDS. After a median observation time of 55 months, incidence of secondary AML/MDS was 1%. Treatment for secondary AML/MDS was as follows: cytarabine (Ara-C)-containing regimens (6-thioguanin, cytarabine, daunorubicin [TAD]/high-dose cytarabine, mitoxantrone [HAM], HAM, Ida-Ara-C (idarubicin + Ara-C), Ida-Flag (idarubicin, fludarabin, Ara-C, G-CSF), and idarubicin, cytarabine, etoposide [ICE]+HAM; n = 11), TAD-chemotherapy (n = 5), other regimens (n = 3), no treatment or supportive care (n = 24), palliative oral chemotherapy (n = 3), and allogeneic stem cell transplantation (n = 9). After 24 months of observation, no difference in freedom from treatment failure and overall survival (2% and 8%, respectively) was observed in patients who developed AML or MDS. CONCLUSION: The prognosis of patients with secondary AML/MDS after primary HD is poor. Thus, emphasis should be made to improve initial treatment in an attempt to prevent this complication.

Acute Disease↗

Jet expansion module for liquid-sampled GC-discharge ionization detection of liquefied gases.

A rugged jet expansion module was designed, built, and utilized to sample liquefied gas for gas chromatography-discharge ionization detector (GC-DID) analysis. The module is inserted at an intermediate stage between a higher pressure sample cylinder and lower pressure gas injection manifold. The title jet module permits selection of liquid-phase or vapor-phase sampling by setting the valve-cylinder orientation up or down (relative to gravity). It consists of a four-way stainless steel cross, plus the following components connected to pipe thread ports: (1) mechanical pressure gauge, -15 to +30 psig; (2) threaded nut with 0.010-in. jet orifice (connect to sample cylinder valve); (3) bellows valve (connect to GC manifold); (4) bellows valve (connect to expansion cylinder). Making use of the jet module, measurement of air concentration in [15N]ammonia and sulfur hexafluoride (single-component) samples was found to be significantly lower in the liquid phase by GC-DID. This compact apparatus enables phase-selective sampling, reduces primary manifold contamination, and improves operator safety.

Journal Article↗

Direct stabilization of lumbar spondylolysis with a hook screw: mean 11-year follow-up period for 113 patients.

STUDY DESIGN: A retrospective study involving 113 patients with a spondylolysis who underwent direct repair with a hook screw was conducted. OBJECTIVES: Spondylolysis with instability can produce low back pain. In adults, fusion of the affected level is the gold standard of treatment. In the adolescent, direct repair of the lysis can save a functional segment. SUMMARY OF BACKGROUND DATA: It has been proved that direct repair of spondylolysis can accomplish restitutio ad integrum for a functional segment. So far, only short-term results are available in the literature. METHODS: This study involved 113 patients who underwent direct repair of spondylolysis with a hook screw according to Morscher. After an average follow-up period of 11 years, the patients were reviewed. The main issue was the question of fusion. For this purpose, plain radiographs were taken. For doubtful cases or for the patient experiencing pain, conventional tomography scans or computed tomography scans were taken. RESULTS: The pseudarthrosis rate was 13.3%. The fusion rate for patients younger than 14 years was higher than that for older patients, especially those older than 20 years. CONCLUSIONS: Direct repair of spondylolysis can be recommended for patients with a growing skeleton, a slight slip, an instability, or failure of conservative treatment. Thereby, a functional segment can be saved with a relatively small operation.

Adolescent↗

New prognostic score based on treatment outcome of patients with relapsed Hodgkin's lymphoma registered in the database of the German Hodgkin's lymphoma study group.

PURPOSE: To evaluate salvage treatment outcome of patients with relapsed Hodgkin's disease (HD) and to distinguish different risk groups using identified prognostic factors. PATIENTS AND METHODS: From 4,754 patients registered in the German Hodgkin's Lymphoma Study Group (GHSG) database between 1988 and 1999, 422 patients with early (n = 170) or late (n = 252) relapsed HD were identified. One hundred seven patients (25%) relapsed after radiotherapy (RT) for early stages, 133 patients (32%) after combined-modality therapy for intermediate stages, and 182 patients (43%) after chemotherapy (CT) and RT to initial bulky disease or residual lymphoma for advanced stages. At relapse, characteristics of these 422 patients (median age, 38 years; range, 17 to 77) were stage III/IV, 45%; B symptoms, 24%; elevated erythrocyte sedimentation rate, 29%; anemia, 13%; and Karnofsky performance score, less than 90 in 13%. At first relapse, salvage treatment was RT in 13%, CT in 54%, and high-dose chemotherapy (HDCT) with autologous stem-cell transplantation (ASCT) in 33%. RESULTS: Median follow-up time after relapse was 45 months. Freedom from second failure (FF2F) and overall survival (OS) were 81% and 89% for relapse after RT, 33% and 46% for early relapse after CT, and 43% and 71% for late relapse after CT, respectively. In multivariate analysis, independent risk factors were time to relapse, clinical stage at relapse, and anemia at relapse. Four subgroups with significantly different FF2F and OS were identified. The prognostic score was predictive for patients who relapsed after RT, CT with conventional CT salvage, and CT with HDCT/ASCT. CONCLUSION: In the GHSG database, time to relapse and clinical stage and anemia at relapse are relevant factors and can be used to form a prognostic score for HD patients at relapse.

Actuarial Analysis↗